Long-term outcomes of laparoscopic heller cardiomyotomy without an anti-reflux procedure

R Gupta1, C Sample, F Bamehriz

  • 1Centre for Minimal Access Surgery, St. Joseph's Healthcare, McMaster University, Hamilton, Ontario, Canada.

Insights

Laparoscopic Heller cardiomyotomy (LHM) without an antireflux procedure effectively treats achalasia. Previous treatments like Botox may increase surgical complexity and complication risks during LHM.

Area of Science:

  • Gastroenterology
  • Minimally Invasive Surgery

Background:

  • Laparoscopic Heller cardiomyotomy (LHM) is a standard treatment for achalasia.
  • Controversies exist regarding the optimal extent of myotomy and the necessity of an antireflux procedure during LHM.

Observation:

  • A retrospective review analyzed 40 patients undergoing LHM for achalasia at a single institution.
  • The study focused on LHM performed without an antireflux procedure.
  • Sixty-five percent of patients had prior medical management (Botox or LES dilatation).

Findings:

  • LHM without an antireflux procedure yielded excellent clinical outcomes, with low dysphagia scores and controlled reflux symptoms in most patients.
  • Patients with prior Botox injections experienced longer operating times and a higher incidence of intraoperative mucosal injury.
  • Postoperative evaluation showed a mean dysphagia score of 0.2 and a mean heartburn score of 3.2.

Implications:

  • LHM without an antireflux procedure is a safe and effective treatment for achalasia.
  • Previous medical interventions for achalasia may complicate LHM and increase the risk of intraoperative injury.
  • Further research may refine surgical techniques for patients with prior treatments.